Publications

2021

85.
Moseri A., Akabayov S. R., Cohen L. S., Naider F. & Anglister J. (2021) The FEBS journal.  Abstract

2020

84.
Kessler N., Akabayov S. R., Moseri A. et al. (2020) The FEBS journal. 5, p. 1648-1663  Abstract [All authors]
83.
Kumar S., Akabayov S. R., Kessler N., Cohen L. S., Solanki J., Naider F., Kay L. E. & Anglister J. (2020) Journal of Biomolecular NMR. 12, p. 681-693  Abstract

2018

82.
Srivastava G., Moseri A., Kessler N., Arshava B., Naider F. & Anglister J. (2018) FEBS Journal. 285, 22, p. 4296-4310  Abstract
81.
Abayev M., Rodrigues J. P. G. L. M., Srivastava G., Arshava B., Jaremko L., Jaremko M., Naider F., Levitt M. & Anglister J. (2018) FEBS Journal. 285, 11, p. 1988-2003  Abstract
80.
Naider F. & Anglister J. (2018) Protein and Peptide Letters. 25, 12, p. 1124-1136  Abstract

2017

79.
Abayev M., Srivastava G., Arshava B., Naider F. & Anglister J. (2017) FEBS Journal. 284, 4, p. 586-601  Abstract
78.
Moseri A., Sinha E., Zommer H., Arshava B., Naider F. & Anglister J. (2017) Vaccine. 35, 2, p. 222-230  Abstract

2016

77.
Anglister J., Srivastava G. & Naider F. (2016) Progress in Nuclear Magnetic Resonance Spectroscopy. 97, p. 40-56  Abstract
76.
Srivastava G., Moseri A., Kessler N., Akabayov S. R., Arshava B., Naider F. & Anglister J. (2016) FEBS Journal. 283, 22, p. 4084-4096  Abstract

2015

75.
Moseri A., Biron Z., Arshava B., Scherf T., Naider F. & Anglister J. (2015) The FEBS journal. 282, 24, p. 4643-57  Abstract
74.
Abayev M., Moseri A., Tchaicheeyan O., Kessler N., Arshava B., Naider F., Scherf T. & Anglister J. (2015) FEBS Journal. 282, 10, p. 1906-1921  Abstract

2014

73.
Moseri A., Schnur E., Noah E. et al. (2014) FEBS Journal. 281, 13, p. 3019-3031  Abstract
[All authors]

2013

72.
Schnur E., Kessler N., Zherdev Y. et al. (2013) FEBS Journal. 280, 9, p. 2068-2084  Abstract
[All authors]
71.
Moseri A., Tantry S., Ding F., Naider F. & Anglister J. (2013) AIDS Research and Human Retroviruses. 29, 4, p. 718-724  Abstract

2011

70.
Nudelman I., Akabayov S. R., Scherf T. & Anglister J. (2011) Journal of the American Chemical Society. 133, 37, p. 14755-14764  Abstract
69.
Schnur E., Noah E., Ayzenshtat I. et al. (2011) Journal of Molecular Biology. 410, 5, p. 778-797  Abstract [All authors]

2010

68.
Moseri A., Tantry S., Sagi Y., Arshava B., Naider F. & Anglister J. (2010) Virology. 401, 2, p. 293-304  Abstract
67.
Nudelman I., Akabayov S. R., Schnur E., Biron Z., Levy R., Xu Y., Yang D. & Anglister J. (2010) Biochemistry. 49, 25, p. 5117-5133  Abstract
66.
Akabayov S. R., Biron Z., Lamken P., Piehler J. & Anglister J. (2010) Biochemistry. 49, 4, p. 687-695  Abstract

2009

65.
Mester B., Manor R., Mor A., Arshava B., Rosen O., Ding F., Naider F. & Anglister J. (2009) Biochemistry. 48, 33, p. 7867-7877  Abstract
64.
Naider F. & Anglister J. (2009) Current Opinion in Structural Biology. 19, 4, p. 473-482  Abstract
63.
Mor A., Segal E., Mester B. et al. (2009) Biochemistry. 48, 15, p. 3288-3303  Abstract
[All authors]
62.
Rosen O. & Anglister J. (2009) Epitope Mapping Protocols. Second Edition ed. p. 37-57 (1Methods in Molecular Biology).  Abstract

2008

61.
Noah E., Biron Z., Naider F., Arshava B. & Anglister J. (2008) Biochemistry. 47, 26, p. 6782-6792  Abstract
60.
Rosen O., Samson A. O. & Anglister J. (2008) Proteins-Structure Function And Bioinformatics. 71, 3, p. 1066-1070  Abstract
59.
Schnur E., Turkov M., Kahn R., Gordon D., Gurevitz M. & Anglister J. (2008) Biochemistry. 47, 3, p. 911-921  Abstract

2007

58.
Anglister J., Rosen O., Sharon M., Tugarinov V., Kessler N. & Levy R. (2007) Journal of biomolecular structure & dynamics. 24, 6, p. 670-670  Abstract

2006

57.
Quadt-Akabayov S. R., Chill J. H., Levy R., Kessler N. & Anglister J. (2006) Protein Science. 15, 11, p. 2656-2668  Abstract
56.
Rosen O., Sharon M., Quadt-Akabayov S. R. & Anglister J. (2006) Proceedings of the National Academy of Sciences of the United States of America. 103, 38, p. 13950-13955  Abstract
54.
Garcia J., Dumy P., Rosen O. & Anglister J. (2006) Biochemistry. 45, 13, p. 4284-4294  Abstract

2005

53.
Biron Z., Khare S., Quadt S., Hayek Y., Naider F. & Anglister J. (2005) Biochemistry. 44, 41, p. 13602-13611  Abstract
52.
NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity
Sharon M., Rosen O. & Anglister J. (2005) Current Opinion In Drug Discovery & Development. 8, 5, p. 601-612 16159022.  Abstract
51.
Samson A., Chill J. & Anglister J. (2005) Biochemistry. 44, 32, p. 10926-10934  Abstract
50.
Rosen O., Chill J., Sharon M., Kessler N., Mester B., Zolla-Pazner S. & Anglister J. (2005) Biochemistry. 44, 19, p. 7250-7258  Abstract

2004

49.
Chill J., Quadt S. & Anglister J. (2004) Biochemistry. 43, 31, p. 10127-10137  Abstract

2003

48.
Chill J., Quadt S., Levy R., Schreiber G. & Anglister J. (2003) Structure. 11, 7, p. 791-802  Abstract
47.
Kessler N., Zvi A., Ji M., Sharon M., Rosen O., Levy R., Gorny M., Zolla-Pazner S. & Anglister J. (2003) Protein Expression and Purification. 29, 2, p. 291-303  Abstract
46.
Sharon M., Kessler N., Levy R., Zolla-Pazner S., Gorlach M. & Anglister J. (2003) Structure. 11, 2, p. 225-236  Abstract

2002

45.
Biron Z., Khare S., Samson A., Hayek Y., Naider F. & Anglister J. (2002) Biochemistry. 41, 42, p. 12687-12696  Abstract
44.
Samson A., Scherf T., Eisenstein M., Chill J. & Anglister J. (2002) Neuron. 35, 2, p. 319-332  Abstract
43.
Sharon M., Gorlach M., Levy R., Hayek Y. & Anglister J. (2002) Protein Expression and Purification. 24, 3, p. 374-383  Abstract
42.
Yao Y., Wang J., Viroonchatapan N., Samson A., Chill J., Rothe E., Anglister J. & Wang Z. (2002) Journal of Biological Chemistry. 277, 15, p. 12613-12621  Abstract
41.
Chill J., Nivasch R., Levy R., Albeck S., Schreiber G. & Anglister J. (2002) Biochemistry. 41, 11, p. 3575-3585  Abstract

2001

40.
Samson A., Chill J., Rodriguez E., Scherf T. & Anglister J. (2001) Biochemistry. 40, 18, p. 5464-5473  Abstract

2000

39.
Froy O., Zilberberg N., Chejanovsky N., Anglister J., Loret E., Shaanan B., Gordon D. & Gurevitz M. (2000) Pest Management Science. 56, 5, p. 472-474  Abstract
38.
Tugarinov V., Zvi A., Levy R., Hayek Y., Matsushita S. & Anglister J. (2000) Structure with Folding & design. 8, 4, p. 385-395  Abstract
37.
Balbach J., Yang J., Weliky D., Steinbach P., Tugarinov V., Anglister J. & Tycko R. (2000) Journal of Biomolecular NMR. 16, 4, p. 313-327  Abstract
36.
Zvi A., Tugarinov V., Faiman G., Horovitz A. & Anglister J. (2000) FEBS Journal. 267, 3, p. 767-779  Abstract
35.
Solution structure of an antibody-bound HIV-1(IIIB)V3 peptide: A cis proline turn linking two beta-hairpin strands
Tugarinov V. & Anglister J. (2000) Journal of biomolecular structure & dynamics. p. 57-63  Abstract

1999

34.
Sharon M., Oren Z., Shai Y. & Anglister J. (1999) Biochemistry. 38, 46, p. 15305-15316  Abstract
33.
A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1(IIIB) V3 peptide
Tugarinov V., Zvi A., Levy R. & Anglister J. (1999) Nature Structural Biology. 6, 4, p. 331-335  Abstract
32.
Tugarinov V., Levy R., Dahan-Schokoroy A. & Anglister J. (1999) Journal of Biomolecular NMR. 13, 2, p. 193-194  Abstract
31.
Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120
Weliky D., Bennett A., Zvi A., Anglister J., Steinbach P. & Tycko R. (1999) Nature Structural Biology. 6, 2, p. 141-145  Abstract
30.
Application of NMR to conformational studies of an HIV peptide bound to a neutralizing antibody
Zvi A. & Anglister J. (1999) Nmr In Supramolecular Chemistry. 526, p. 117-132  Abstract

1998

29.
The principal neutralizing determinant of HIV-1(IIIB): Conformation Of the peptide bound to a neutralizing antibody studied by 2D-NMR
Zvi A. & Anglister J. (1998) International Journal of Peptide Research and Therapeutics. 5, 6-May, p. 357-364  Abstract

1997

28.
Zvi A., Feigelson D., Hayek Y. & Anglister J. (1997) Biochemistry. 36, 28, p. 8619-8627  Abstract
27.
Scherf T., Balass M., Fuchs S., KatchalskiKatzir E. & Anglister J. (1997) Proceedings of the National Academy of Sciences of the United States of America. 94, 12, p. 6059-6064  Abstract
26.
Tugarinov V., Kustanovich I., Zilberberg N., Gurevitz M. & Anglister J. (1997) Biochemistry. 36, 9, p. 2414-2424  Abstract

1996

25.
Faiman G., Levy R., Anglister J. & Horovitz A. (1996) Journal of Biological Chemistry. 271, 23, p. 13829-13833  Abstract

1995

24.
Anglister J., REN H., KLEE C. & BAX A. (1995) FEBS Letters. 375, 2-Jan, p. 108-112  Abstract
23.
ZVI A., KUSTANOVICH I., HAYEK Y., MATSUSHITA S. & Anglister J. (1995) FEBS Letters. 368, 2, p. 267-270  Abstract
22.
STRUCTURAL DIVERSITY IN A CONSERVED CHOLERA-TOXIN EPITOPE INVOLVED IN GANGLIOSIDE BINDING
Shoham M., Scherf T., Anglister J., LEVITT M., MERRITT E. & HOL W. (1995) Protein Science. 4, 5, p. 841-848  Abstract
21.
ZVI A., KUSTANOVICH I., FEIGELSON D., Levy R., Eisenstein M., MATSUSHITA S., RICHALETSECORDEL P., REGENMORTEL M. & Anglister J. (1995) FEBS Journal. 229, 1, p. 178-187  Abstract
20.
NMR OBSERVATION OF INTERACTIONS IN THE COMBINING SITE REGION OF AN ANTIBODY USING A SPIN-LABELED PEPTIDE ANTIGEN AND NOESY DIFFERENCE SPECTROSCOPY
Scherf T., HILLER R. & Anglister J. (1995) FASEB Journal. 9, 1, p. 120-126  Abstract
19.
Anglister J., Scherf T., ZILBER B. & Levy R. (1995) Biopolymers. 37, 6, p. 383-389  Abstract

1994

18.
Anglister J., GRZESIEK S., WANG A., REN H., KLEE C. & BAX A. (1994) Biochemistry. 33, 12, p. 3540-3547  Abstract

1993

17.
Anglister J., Scherf T., ZILBER B., Levy R., ZVI A., HILLER R. & FEIGELSON D. (1993) FASEB Journal. 7, 12, p. 1154-1162  Abstract
16.
A T(1-RHO)-FILTERED 2-DIMENSIONAL TRANSFERRED NOE SPECTRUM FOR STUDYING ANTIBODY INTERACTIONS WITH PEPTIDE ANTIGENS
Scherf T. & Anglister J. (1993) Biophysical Journal. 64, 3, p. 754-761  Abstract

1992

15.
ZVI A., HILLER R. & Anglister J. (1992) Biochemistry. 31, 30, p. 6972-6979  Abstract
14.
Scherf T., HILLER R., Naider F., LEVITT M. & Anglister J. (1992) Biochemistry. 31, 30, p. 6884-6897  Abstract

1991

13.
Anglister J. & Naider F. (1991) Molecular Design and Modeling: Concepts and Applications. Vol. 203. p. 228-241  Abstract

1990

12.
ZILBER B., Scherf T., LEVITT M. & Anglister J. (1990) Biochemistry. 29, 43, p. 10032-10041  Abstract
11.
USE OF DEUTERIUM LABELING IN NMR-STUDIES OF ANTIBODY COMBINING SITE STRUCTURE
Anglister J. (1990) Quarterly Reviews of Biophysics. 23, 2, p. 175-203  Abstract

1989

1988

7.
FREY T., Anglister J. & MCCONNELL H. (1988) Biochemistry. 27, 14, p. 5161-5165  Abstract
6.
Anglister J., JACOB C., ASSULIN O., AST G., PINKER R. & Arnon R. (1988) Biochemistry. 27, 2, p. 717-724  Abstract

1987

5.
Anglister J., BOND M., FREY T., LEAHY D., LEVITT M., MCCONNELL H., RULE G., TOMASELLO J. & WHITTAKER M. (1987) Biochemistry. 26, 19, p. 6058-6064  Abstract

1983

3.
Anglister J. & STEINBERG I. (1983) Journal of Chemical Physics. 78, 9, p. 5358-5368  Abstract

1981

2.
Anglister J. & STEINBERG I. (1981) Journal of Chemical Physics. 74, 2, p. 786-791  Abstract

1979

1.
Anglister J. & STEINBERG I. (1979) Chemical Physics Letters. 65, 1, p. 50-54  Abstract